APA (7th ed.) Citation

Varga, G., Nagy, Z., Demeter, J., Kosztolányi, S., Szomor, Á., Alizadeh, H., . . . Mikala, G. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma. Pathology & Oncology Research: Official Journal of the Arányi Lajos Foundation, 25(4), 1615. https://doi.org/10.1007/s12253-019-00607-2

Chicago Style (17th ed.) Citation

Varga, Gergely, et al. "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma." Pathology & Oncology Research: Official Journal of the Arányi Lajos Foundation 25, no. 4 (2019): 1615. https://doi.org/10.1007/s12253-019-00607-2.

MLA (9th ed.) Citation

Varga, Gergely, et al. "Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma." Pathology & Oncology Research: Official Journal of the Arányi Lajos Foundation, vol. 25, no. 4, 2019, p. 1615, https://doi.org/10.1007/s12253-019-00607-2.